Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 31,514 shares at $17.65 ($565K) on 2020-10-21, disclosed to the SEC on 2020-10-22.
Open-market sale of $565k KALV by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.26 | 5,600 | $97K | 17.1% |
| 2 | $17.26 | 5,600 | $97K | 17.1% |
| 3 | $18.00 | 2,300 | $41K | 7.3% |
| 4 | $17.65 | 3,600 | $64K | 11.3% |
| 5 | $17.65 | 3,600 | $64K | 11.3% |
| 6 | $18.75 | 5,407 |
| $101K |
| 18.0% |
| 7 | $18.75 | 5,407 | $101K | 18.0% |
| Total | $17.91 avg | 31,514 | $565K | 100% |
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |